42
Participants
Start Date
October 13, 2015
Primary Completion Date
November 27, 2022
Study Completion Date
November 28, 2023
Carboplatin
Participants will be treated with carboplatin (area under the curve 5 (AUC5) will be used to determine the dosage) twice daily, days 1 and 2 and once a day on day 3 (5 doses) during each 21 day cycle of treatment.
Paclitaxel
Participants will be treated with paclitaxel 175 mg/m\^2 twice daily, days 1 and 2 and once a day on day 3 (5 doses) during each 21 day cycle of treatment.
AZD1775
Participants will receive AZD1775 225 mg twice daily, days 1 and 2 and once a day on day 3 (5 doses) during each 21 day cycle of treatment.
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Ohio State University Comprehensive Cancer Center, Columbus
H. Lee Moffitt Cancer Center and Research Institute
OTHER